Načítá se...
Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance
Oncolytic virotherapy (OVT) has been suggested to be effective. However, the suppressive effects of checkpoints and insufficient costimulatory signals limit OVT-induced antitumor immune responses. In this study, we constructed a replicative adenovirus, Ad5sPVR, that expresses the soluble extracellul...
Uloženo v:
| Vydáno v: | Mol Ther Oncolytics |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Gene & Cell Therapy
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851489/ https://ncbi.nlm.nih.gov/pubmed/33575467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.11.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|